Vitamin D analogs as anabolic agents.
Brown
T A
TA
Pfizer Research and Development, Groton, CT, USA. thomas.brown@pfizer.com
D045930:Anabolic Agents / Q000627:therapeutic use*; D000818:Animals; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001862:Bone Resorption / Q000517:prevention & control*; D002117:Calcitriol / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D023421:Models, Animal; D010052:Ovariectomy; D051381:Rats; D014807:Vitamin D / Q000031:analogs & derivatives*
C468519:2-methylene-1,25-dihydroxy-19-norvitamin D3; D045930:Anabolic Agents; D050071:Bone Density Conservation Agents; D014807:Vitamin D; D002117:Calcitriol